1. Home
  2. SNGX vs CETY Comparison

SNGX vs CETY Comparison

Compare SNGX & CETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • CETY
  • Stock Information
  • Founded
  • SNGX 1987
  • CETY 1993
  • Country
  • SNGX United States
  • CETY United States
  • Employees
  • SNGX N/A
  • CETY N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • CETY Power Generation
  • Sector
  • SNGX Health Care
  • CETY Utilities
  • Exchange
  • SNGX Nasdaq
  • CETY Nasdaq
  • Market Cap
  • SNGX 13.8M
  • CETY 12.2M
  • IPO Year
  • SNGX 1987
  • CETY N/A
  • Fundamental
  • Price
  • SNGX $1.34
  • CETY $1.53
  • Analyst Decision
  • SNGX Strong Buy
  • CETY
  • Analyst Count
  • SNGX 1
  • CETY 0
  • Target Price
  • SNGX $6.00
  • CETY N/A
  • AVG Volume (30 Days)
  • SNGX 697.0K
  • CETY 228.4K
  • Earning Date
  • SNGX 11-10-2025
  • CETY 11-18-2025
  • Dividend Yield
  • SNGX N/A
  • CETY N/A
  • EPS Growth
  • SNGX N/A
  • CETY N/A
  • EPS
  • SNGX N/A
  • CETY N/A
  • Revenue
  • SNGX N/A
  • CETY $1,743,723.00
  • Revenue This Year
  • SNGX N/A
  • CETY N/A
  • Revenue Next Year
  • SNGX N/A
  • CETY N/A
  • P/E Ratio
  • SNGX N/A
  • CETY N/A
  • Revenue Growth
  • SNGX N/A
  • CETY N/A
  • 52 Week Low
  • SNGX $1.09
  • CETY $1.50
  • 52 Week High
  • SNGX $6.23
  • CETY $19.05
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 34.06
  • CETY 39.55
  • Support Level
  • SNGX $1.54
  • CETY $2.27
  • Resistance Level
  • SNGX $1.61
  • CETY $2.66
  • Average True Range (ATR)
  • SNGX 0.10
  • CETY 0.20
  • MACD
  • SNGX 0.01
  • CETY -0.16
  • Stochastic Oscillator
  • SNGX 8.70
  • CETY 1.94

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About CETY Clean Energy Technologies Inc.

Clean Energy Technologies Inc is clean energy and environmentally sustainable technologies company offering heat recovery solutions products. In addition, it also provides engineering and manufacturing solutions focused on other energy-efficient and environmentally sustainable technologies. The company's principal product is the Clean Cycle generator, offered by Heat Recovery Solutions. The company's engineering and manufacturing resources support its heat recovery solutions business. It has four segments: Clean Energy HRS & CETY Europe, CETY Renewables Waste to Energy Solutions, Engineering and Manufacturing Business and CETY HK. It serves various markets, including industrial, aerospace, military, instrumentation, and medical.

Share on Social Networks: